Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood. METHODS: We performed a prospective cohort study of adults with solid-organ or hematologic cancers to evaluate anti–SARS-CoV-2 immunoglobulin A/M/G spike antibodies, neutralization, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Naranbhai, Vivek, Pernat, Claire A., Gavralidis, Alexander, St Denis, Kerri J., Lam, Evan C., Spring, Laura M., Isakoff, Steven J., Farmer, Jocelyn R., Zubiri, Leyre, Hobbs, Gabriela S., How, Joan, Brunner, Andrew M., Fathi, Amir T., Peterson, Jennifer L., Sakhi, Mustafa, Hambelton, Grace, Denault, Elyssa N., Mortensen, Lindsey J., Perriello, Lailoo A., Bruno, Marissa N., Bertaux, Brittany Y., Lawless, Aleigha R., Jackson, Monica A., Niehoff, Elizabeth, Barabell, Caroline, Nambu, Christian N., Nakajima, Erika, Reinicke, Trenton, Bowes, Cynthia, Berrios-Mairena, Cristhian J., Ofoman, Onosereme, Kirkpatrick, Grace E., Thierauf, Julia C., Reynolds, Kerry, Willers, Henning, Beltran, Wilfredo-Garcia, Dighe, Anand S., Saff, Rebecca, Blumenthal, Kimberly, Sullivan, Ryan J., Chen, Yi-Bin, Kim, Arthur, Bardia, Aditya, Balazs, Alejandro B., Iafrate, A. John, Gainor, Justin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
RAPID COMMUNICATIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683230/
https://www.ncbi.nlm.nih.gov/pubmed/34752147
http://dx.doi.org/10.1200/JCO.21.01891

Ejemplares similares

Ejemplares similares